康惠制药 (603139.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(康惠制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 472,228,266.33269,296,817.15123,792,050.57491,511,206.02375,140,799.38243,021,887.86117,729,916.33
 营业利润(元) 2,806,588.3711,724,094.778,851,762.10-75,691,412.6120,192,721.7117,729,234.6011,419,086.29
 利润总额(元) 2,720,313.1711,634,366.148,946,731.80-82,742,181.8319,929,242.0617,586,757.7811,263,451.56
 净利润(元) 1,105,939.768,927,928.078,281,339.16-76,784,697.7916,131,708.2415,121,470.579,153,640.00
 归属于母公司股东的净利润(元) 9,221,645.6312,599,138.318,206,330.75-63,055,947.6016,264,611.3313,924,730.338,791,930.72
盈利能力:
 销售毛利率(%) 29.4233.4934.5840.5241.2341.0343.22
 销售净利率(%) 0.233.326.69-15.624.306.227.78
 净资产收益率(%) 0.901.240.81----
 总资产报酬率ROA(%) 0.600.610.51----
 投入资本回报率ROIC(%) 0.570.790.52-4.151.030.890.57
营运能力:
 存货周转率(次) 1.820.900.66----
 应收账款周转率(次) 2.421.520.75----
 总资产周转率(次) 0.230.130.07----
偿债能力:
 资产负债率(%) 49.7950.2646.0943.6842.0540.9638.84
 股东权益比率(%) 45.9645.0851.1853.4554.5555.3857.42
 已获利息倍数(倍) 1.2916.5416.57-9.566.667.8210.96
 流动比率 1.281.271.741.611.671.681.96
 速动比率 0.780.771.331.211.291.351.57
发展能力:
 营业收入增长率(%) 25.8810.815.1511.0111.9513.4721.68
 营业利润增长率(%) -86.10-33.87-22.48-295.40-20.450.587.93
 税后利润增长率(%) -43.30-9.52-6.66-272.84-24.80-9.00-3.44
 净资产增长率(%) -6.88-6.35-6.97-6.973.253.663.80
 总资产增长率(%) 10.5415.064.38-2.0711.0310.869.10

前瞻产业研究院